表紙:バルビツール酸系薬剤の世界市場規模調査:薬剤タイプ別、疾患タイプ別、流通チャネル別、地域別予測(2022年~2028年)
市場調査レポート
商品コード
1099682

バルビツール酸系薬剤の世界市場規模調査:薬剤タイプ別、疾患タイプ別、流通チャネル別、地域別予測(2022年~2028年)

Global Barbiturate Drugs Market Size study, by Drug Type, by Disease Type, by Distribution Channel, and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
バルビツール酸系薬剤の世界市場規模調査:薬剤タイプ別、疾患タイプ別、流通チャネル別、地域別予測(2022年~2028年)
出版日: 2022年06月21日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

高齢者人口の増加、不眠症の有病率の上昇、社会におけるストレスレベルの上昇は市場の成長を牽引しています。

しかし、バルビツール酸系薬剤に伴う副作用が市場成長を抑制していると考えられます。

当レポートでは、世界のバルビツール酸系薬剤市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のバルビツール酸系薬剤市場の定義と範囲

第3章 世界のバルビツール酸系薬剤市場力学

  • バルビツール酸系薬剤市場の影響分析(2020年~2028年)

第4章 世界のバルビツール酸系薬剤市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価:COVID-19の影響

  • 業界に対するCOVID-19の全体的な影響の評価
  • COVID-19以前およびCOVID-19以後の市場シナリオ

第6章 世界のバルビツール酸系薬剤市場:疾患タイプ別

  • 市場スナップショット
  • 世界のバルビツール酸系薬市場実績:疾患タイプ別-潜在分析
  • 世界のバルビツール酸系薬市場の推定と予測(100万米ドル)(2018年~2028年):疾患タイプ別
  • バルビツール酸系薬剤市場、サブセグメント分析
    • てんかん
    • 不眠症
    • 鎮静
    • その他

第7章 世界のバルビツール酸系薬剤市場:薬剤タイプ別

  • 市場スナップショット
  • 世界のバルビツール酸系薬市場実績:薬剤タイプ別-潜在分析
  • 世界のバルビツール酸系薬市場の推定と予測(100万米ドル)(2018年~2028年):薬剤タイプ別
  • バルビツール酸系薬剤市場、サブセグメント分析
    • 超短時間作用型バルビツール酸塩
    • 短時間作用型バルビツール酸塩
    • 長時間作用型バルビツール酸塩
    • 併用薬

第8章 世界のバルビツール酸系薬剤市場:流通チャネル別

  • 市場スナップショット
  • 世界のバルビツール酸系薬市場実績:流通チャネル別-潜在分析
  • 世界のバルビツール酸系薬市場の推定と予測(100万米ドル)(2018年~2028年):流通チャネル別
  • バルビツール酸系薬剤市場、サブセグメント分析
    • 小売薬局
    • 病院薬局
    • その他

第9章 世界のバルビツール酸系薬剤市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Akorn Operating Company LLC
    • Par Pharmaceutical
    • Intas Pharmaceuticals Ltd.
    • Samarth Life Sciences Pvt. Ltd.
    • Centurion Healthcare Private Limited
    • Ethypharm
    • Abbott

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Barbiturate Drugs Market, report scope
  • TABLE 1. Global Barbiturate Drugs Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 2. Global Barbiturate Drugs Market estimates & forecasts by Drug Type 2018-2028 (USD Million)
  • TABLE 3. Global Barbiturate Drugs Market estimates & forecasts by Disease Type 2018-2028 (USD Million)
  • TABLE 4. Global Barbiturate Drugs Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
  • TABLE 5. Global Barbiturate Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Barbiturate Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Barbiturate Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Barbiturate Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Barbiturate Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Barbiturate Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Barbiturate Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Barbiturate Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Barbiturate Drugs Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Barbiturate Drugs Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Barbiturate Drugs Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Barbiturate Drugs Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Barbiturate Drugs Market
  • TABLE 55. List of primary sources, used in the study of global Barbiturate Drugs Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Barbiturate Drugs Market, research methodology
  • FIG 2. Global Barbiturate Drugs Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Barbiturate Drugs Market, key trends 2021
  • FIG 5. Global Barbiturate Drugs Market, growth prospects 2022-2028
  • FIG 6. Global Barbiturate Drugs Market, porters 5 force model
  • FIG 7. Global Barbiturate Drugs Market, pest analysis
  • FIG 8. Global Barbiturate Drugs Market, value chain analysis
  • FIG 9. Global Barbiturate Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Barbiturate Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Barbiturate Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Barbiturate Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Barbiturate Drugs Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Barbiturate Drugs Market, regional snapshot 2018 & 2028
  • FIG 15. North America Barbiturate Drugs Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Barbiturate Drugs Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Barbiturate Drugs Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Barbiturate Drugs Market 2018 & 2028 (USD Million)
  • FIG 19. Global Barbiturate Drugs Market, company market share analysis (2021)
目次

Global Barbiturate Drugs Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Barbiturates are drugs that affect the central nervous system. Barbiturates are chemical derivatives of barbituric acid. Barbiturate medicines come in a variety of forms, but they all have a relaxing impact on the central nervous system and are used to treat anxiety in therapeutic settings. Sleeplessness, Epilepsy, and status epilepticus are all treated with barbiturates. Barbiturate medications come in tablet form and can be administered either orally or intravenously. Increase in geriatric population and rise in prevalence of target diseases drive the growth of Barbiturate drug market. For instance, as per Statista, Japan had the largest proportion of the total population over the age of 65 in 2021. Japan boasts the world's oldest population, with 29 percent of the population over 65. Germany, on the other hand, will have 22% of its population over the age of 65 in 2021. Furthermore, according to Gallup, employees in the United States and Canada saw the greatest levels of daily stress (57 percent), whereas stress in Western Europe fell to 39 percent in 2019 from 46 percent in 2018. Also, with the rise in prevalence of insomnia and rising stress levels in society the adoption & demand for Barbiturate Drugs is likely to increase the market growth during the forecast period However, side effects associated with Barbiturate Drugs impede the growth of the market over the forecast period of2022-2028.

The key regions considered for the global Barbiturate Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share globally, owing to the highest percentage of insomnia affected patients. However, Barbiturate medications are predicted to be the second most popular in Asia Pacific, excluding Japan. The growing stress level of the working population, as well as the quickly developing healthcare infrastructure, may be contributed to the market's growth in the region.

Major market players included in this report are:

Par Pharmaceutical

Intas Pharmaceuticals Ltd.

Samarth Life Sciences Pvt. Ltd.

Centurion Healthcare Private Limited

Ethypharm

Abbott

Akorn Operating Company LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Ultra-Short Acting Barbiturate

Short-Acting Barbiturate

Long-Acting Barbiturate

Combination Drugs

By Disease Type:

Epilepsy

Insomnia

Sedation

Other Disease Type

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Other Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Barbiturate Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Barbiturate Drugs Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Barbiturate Drugs Market, by Drug Type, 2020-2028 (USD Million)
    • 1.2.3. Barbiturate Drugs Market, by Disease Type, 2020-2028 (USD Million)
    • 1.2.4. Barbiturate Drugs Market, by Distribution Channel, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Barbiturate Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Barbiturate Drugs Market Dynamics

  • 3.1. Barbiturate Drugs Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in Geriatric Population
      • 3.1.1.2. Rise in Prevalence of Target Diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side Effects Associated with Barbiturate Drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in prevalence of insomnia
      • 3.1.3.2. Rising stress levels in society

Chapter 4. Global Barbiturate Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Barbiturate Drugs Market, by Disease Type

  • 6.1. Market Snapshot
  • 6.2. Global Barbiturate Drugs Market by Disease Type, Performance - Potential Analysis
  • 6.3. Global Barbiturate Drugs Market Estimates & Forecasts by Disease Type, 2018-2028 (USD Million)
  • 6.4. Barbiturate Drugs Market, Sub Segment Analysis
    • 6.4.1. Epilepsy
    • 6.4.2. Insomnia
    • 6.4.3. Sedation
    • 6.4.4. Other Disease Type

Chapter 7. Global Barbiturate Drugs Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Barbiturate Drugs Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Barbiturate Drugs Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Million)
  • 7.4. Barbiturate Drugs Market, Sub Segment Analysis
    • 7.4.1. Ultra-Short Acting Barbiturate
    • 7.4.2. Short-Acting Barbiturate
    • 7.4.3. Long-Acting Barbiturate
    • 7.4.4. Combination Drugs

Chapter 8. Global Barbiturate Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Barbiturate Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Barbiturate Drugs Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Million)
  • 8.4. Barbiturate Drugs Market, Sub Segment Analysis
    • 8.4.1. Retail Pharmacies
    • 8.4.2. Hospital Pharmacies
    • 8.4.3. Other Pharmacies

Chapter 9. Global Barbiturate Drugs Market, Regional Analysis

  • 9.1. Barbiturate Drugs Market, Regional Market Snapshot
  • 9.2. North America Barbiturate Drugs Market
    • 9.2.1. U.S. Barbiturate Drugs Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Disease Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-202
    • 9.2.2. Canada Barbiturate Drugs Market
  • 9.3. Europe Barbiturate Drugs Market Snapshot
    • 9.3.1. U.K. Barbiturate Drugs Market
    • 9.3.2. Germany Barbiturate Drugs Market
    • 9.3.3. France Barbiturate Drugs Market
    • 9.3.4. Spain Barbiturate Drugs Market
    • 9.3.5. Italy Barbiturate Drugs Market
    • 9.3.6. Rest of Europe Barbiturate Drugs Market
  • 9.4. Asia-Pacific Barbiturate Drugs Market Snapshot
    • 9.4.1. China Barbiturate Drugs Market
    • 9.4.2. India Barbiturate Drugs Market
    • 9.4.3. Japan Barbiturate Drugs Market
    • 9.4.4. Australia Barbiturate Drugs Market
    • 9.4.5. South Korea Barbiturate Drugs Market
    • 9.4.6. Rest of Asia Pacific Barbiturate Drugs Market
  • 9.5. Latin America Barbiturate Drugs Market Snapshot
    • 9.5.1. Brazil Barbiturate Drugs Market
    • 9.5.2. Mexico Barbiturate Drugs Market
  • 9.6. Rest of The World Barbiturate Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Akorn Operating Company LLC
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Par Pharmaceutical
    • 10.2.3. Intas Pharmaceuticals Ltd.
    • 10.2.4. Samarth Life Sciences Pvt. Ltd.
    • 10.2.5. Centurion Healthcare Private Limited
    • 10.2.6. Ethypharm
    • 10.2.7. Abbott

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption